Ticker Information
Ticker
BIIBCompany Name
BIOGEN INCSector
HealthcareIndustry
Drug Manufacturers - GeneralExchange
NASDAQBIOGEN INC - Capital Expenditure Chart Analysis (TTM)
Date Range
Zoom
BIIB - Capital Expenditure Historical Data
| Date | Capital Expenditure |
|---|---|
| 2026-03-31 | $ 189.5M |
| 2025-12-31 | $ 185.4M |
| 2025-09-30 | $ 191.5M |
| 2025-06-30 | $ 284.4M |
| 2025-03-31 | $ 197.4M |
| 2024-12-31 | $ 271.2M |
| 2024-09-30 | $ 270.1M |
| 2024-06-30 | $ 213.3M |
| 2024-03-31 | $ 360.7M |
| 2023-12-31 | $ 311.4M |
Key Performance Insights, Last 5 Years
- ✓ BIOGEN INC's latest trailing twelve months (TTM) CapEx stands at $ 189.5M.
- ✓ Over the past 5 years, BIOGEN INC's average CapEx has been $ 144.74M.
- ✓ The median CapEx for BIOGEN INC during this period was $ 227.75M
- ✓ BIOGEN INC reached its highest CapEx over the past 5 years at $ 360.7M.
- ✓ The lowest CapEx recorded by BIOGEN INC in the same timeframe $ -358.3M
BIOGEN INC's CapEx vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx Benchmarks
| Company | CapEx |
|---|---|
| ZTS : ZOETIS INC | $ 572M |
| DGX : QUEST DIAGNOSTICS INC | $ 524M |
| A : AGILENT TECHNOLOGIES INC | $ 403M |
| RMD : RESMED INC | $ 135.74M |
| STE : STERIS PLC | $ 330.09M |
| ZBH : ZIMMER BIOMET HOLDINGS INC | $ 534.2M |
| ONC : BEONE MEDICINES LTD | $ 170.22M |
| OGN : ORGANON & CO | $ 166M |
| IQV : IQVIA HOLDINGS INC | $ 513M |
| LH : LABCORP HOLDINGS INC | $ 429.5M |
Similar metrics to CapEx:
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Property Plant & Equipment (Net) - [Balance Sheet] A component of [Assets] representing the assets that are either property, plant or equipment after accumulated depreciation, depletion and amortization. Common examples include buildings, land, furniture, and other physical assets that a company has purchased to run its business.
Definition of Capital Expenditure
[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
BIIB - Capital Expenditure, Last 5 years
Minimum
Sep 30, 2022
Maximum
Mar 31, 2024
Average
Median
CapEx Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.65M with a standard deviation of $ 16.08M.
The following table provides additional summary stats:
CapEx in the Market:
| filtered constituents | 2.93K |
|---|---|
| min | $ -43.7M |
| max | $ 64.49M |
| average | $ 9.65M |
| median | $ 1.7M |
| std | $ 16.08M |